Cooper Consumer Health is a European leader in selfcare (non-prescription medicines, food supplements, and medical devices), established in January 2016 by private equity firm Charterhouse Capital Partners. It originates from the combination of French laboratoire Cooper and Dutch Vemedia Consumer Health.
Since then, Cooper Consumer Health has grown through successful follow-on acquisitions of strong brand portfolios, such as Hexomédine, Essaven, Dacryoserum.
Today, Cooper Consumer Health holds dominant positions in France, the Netherlands, Belgium, Italy, Spain, Portugal, and Hong-Kong. Its leading brands include Oenobiol, Valdispert, Pouxit, Insect Ecran, Excilor, and Audispray.
To find out more, visit us on cooperconsumerhealth.eu
Since then, Cooper Consumer Health has grown through successful follow-on acquisitions of strong brand portfolios, such as Hexomédine, Essaven, Dacryoserum.
Today, Cooper Consumer Health holds dominant positions in France, the Netherlands, Belgium, Italy, Spain, Portugal, and Hong-Kong. Its leading brands include Oenobiol, Valdispert, Pouxit, Insect Ecran, Excilor, and Audispray.
To find out more, visit us on cooperconsumerhealth.eu
Location: France, Ile-de-France
Employees: 501-1000
Founded date: 2016
Investors 4
| Date | Name | Website |
| 09.11.2021 | CVC Capita... | cvc.com |
| - | Damier Gro... | damiergrou... |
| 06.11.2020 | Charterhou... | charterhou... |
| 12.12.2021 | Avista Cap... | avistacap.... |
Mentions in press and media 6
| Date | Title | Description |
| 03.01.2024 | Fred Duchin Joins Avista Capital Partners as a Strategic Executive | NEW YORK, NY – January 2, 2024 – Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that Fred Duchin has joined the firm as a Strategic Executive. Mr. Duchin is the Chairman ... |
| 02.10.2023 | Cooper Consumer Health Enters Into Exclusive Negotiations with Viatris for the Acquisition of Viatris’ Over-the-Counter (OTC) Business | 2nd October 2023 Cooper Consumer Health (“Cooper CH”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce today that it has entered into exclusive negotiations with Viatris Inc. (“Viatr... |
| 25.08.2022 | Avista Capital Partners Acquires WellSpring Consumer Healthcare | Avista to leverage its expertise and resources to accelerate WellSpring’s growth trajectory for the benefit of all stakeholders NEW YORK, August 23, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusive... |
| 12.03.2021 | Charterhouse Capital Partners enters into exclusive negotiations for the sale of Cooper | London, 12th March 2021: Charterhouse Capital Partners LLP (“Charterhouse”), one of the longest established private equity firms operating in Europe, announces today that it has entered into exclusive negotiations for the sale of a majority... |
| - | Avista Capital Partners Announces Leadership Transition, New Partners and Promotions | Thompson Dean to Transition to Chairman; David Burgstahler to Become Sole Managing Partner Josh Tamaroff and Alex Yu named Partners as Avista continues to realize significant growth NEW YORK, Aug. 18, 2021 /PRNewswire/ — Avista Capital Pa... |
| - | Cooper Consumer Health announces the appointment of Bart Meermans as CEO and the acquisition of Lashilé Beauty | Paris, France, November 8, 2021 — Cooper Consumer Health (“Cooper”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce the appointment of Bart Meermans as its new Chief Executive Office... |